AV
Atlas Venture
Venture CapitalActiveAtlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
514
Investments
10
Exits
$3.2B
AUM
1.9%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Atlas Venture.
Investment Thesis & Strategy
Atlas Venture invests in seed and early-stage biotech companies, focusing on creating and funding innovative ventures within the healthcare sector.
Investment Activity
Deals per year over the last 8 years
1
20131
20140
20155
20161
20171
20182
20191
2020Portfolio Companies
Selected investments from their portfolio of 514 companies
A
Adagio Therapeutics
Biotech · Series A, 2020
V
Verve Therapeutics
Biotech · Series A, 2019
T
Tessera Therapeutics
Biotech · Series A, 2019
S
Sana Biotechnology
Biotech · Series A, 2018
O
Obsidian Therapeutics
Biotech · Series A, 2017
S
Surface Oncology
Biotech · Series A, 2016
C
Codiak BioSciences
Biotech · Series A, 2016
K
Kymera Therapeutics
Biotech · Series A, 2016
X
Xilio Therapeutics
Biotech · Series A, 2016
G
Gemini Therapeutics
Biotech · Series A, 2016
I
Intellia Therapeutics
Biotech · Series A, 2014
A
Avidity Biosciences
Biotech · Series A, 2013
Notable Exits
CompanyTypeYearValue / Acquirer
StripeIPO2025$95B
CohesityIPO2024$5B
RubrikIPO2024$6B
SoundHound AIIPO2022$350M
OutSystemsAcquisition2021$9B
DocuSignIPO2018$4B
WayfairIPO2014$2.5B
LiverampIPO2013$300M
InstagramAcquisition2012$1B
VistaprintIPO2005$1.2B
Frequently Asked Questions
Atlas Venture focuses on Series A, Series B, Series C+ stage investments.
Related Investors
General Catalyst
Cambridge, United States · 737 deals
F-Prime Capital
Cambridge, United States · 228 deals
MPM Capital
Cambridge, United States · 223 deals
Accomplice
Cambridge, United States · 222 deals
Flagship Pioneering
Cambridge, United States · 213 deals
CVP Management
Cambridge, United States · 149 deals